BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34291563)

  • 1. SD-36 promotes growth inhibition and induces apoptosis via suppression of Mcl-1 in glioma.
    Kong S; Ge X; Li X; Liu Z; Zhang R; Yang M; Wang Z; Li Z
    J Cell Mol Med; 2021 Sep; 25(17):8261-8270. PubMed ID: 34291563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.
    Xu JX; Yang Y; Zhang X; Luan XP
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1922-1931. PubMed ID: 32141561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.
    Iwamaru A; Szymanski S; Iwado E; Aoki H; Yokoyama T; Fokt I; Hess K; Conrad C; Madden T; Sawaya R; Kondo S; Priebe W; Kondo Y
    Oncogene; 2007 Apr; 26(17):2435-44. PubMed ID: 17043651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein.
    Zhou H; Bai L; Xu R; Zhao Y; Chen J; McEachern D; Chinnaswamy K; Wen B; Dai L; Kumar P; Yang CY; Liu Z; Wang M; Liu L; Meagher JL; Yi H; Sun D; Stuckey JA; Wang S
    J Med Chem; 2019 Dec; 62(24):11280-11300. PubMed ID: 31747516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin disrupts pathological features of glioma cells and associated macrophages independent of apoptosis induction.
    Roberts NB; Alqazzaz A; Hwang JR; Qi X; Keegan AD; Kim AJ; Winkles JA; Woodworth GF
    J Neurooncol; 2018 Dec; 140(3):497-507. PubMed ID: 30132163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bortezomib-induced sensitization of malignant human glioma cells to vorinostat-induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl-1 cleavage, and DNA damage.
    Premkumar DR; Jane EP; Agostino NR; DiDomenico JD; Pollack IF
    Mol Carcinog; 2013 Feb; 52(2):118-33. PubMed ID: 22086447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
    Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
    J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockage of the STAT3 signaling pathway with a decoy oligonucleotide suppresses growth of human malignant glioma cells.
    Gu J; Li G; Sun T; Su Y; Zhang X; Shen J; Tian Z; Zhang J
    J Neurooncol; 2008 Aug; 89(1):9-17. PubMed ID: 18415045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRD4 Levels Determine the Response of Human Lung Cancer Cells to BET Degraders That Potently Induce Apoptosis through Suppression of Mcl-1.
    Zong D; Gu J; Cavalcante GC; Yao W; Zhang G; Wang S; Owonikoko TK; He X; Sun SY
    Cancer Res; 2020 Jun; 80(11):2380-2393. PubMed ID: 32156781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cells.
    Zhang L; Peterson TE; Lu VM; Parney IF; Daniels DJ
    PLoS One; 2019; 14(7):e0220569. PubMed ID: 31361777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells.
    Ciaglia E; Torelli G; Pisanti S; Picardi P; D'Alessandro A; Laezza C; Malfitano AM; Fiore D; Pagano Zottola AC; Proto MC; Catapano G; Gazzerro P; Bifulco M
    Oncotarget; 2015 Jun; 6(17):15464-81. PubMed ID: 26008966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
    Duan Z; Bradner J; Greenberg E; Mazitschek R; Foster R; Mahoney J; Seiden MV
    Mol Pharmacol; 2007 Nov; 72(5):1137-45. PubMed ID: 17675586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo.
    Bai L; Zhou H; Xu R; Zhao Y; Chinnaswamy K; McEachern D; Chen J; Yang CY; Liu Z; Wang M; Liu L; Jiang H; Wen B; Kumar P; Meagher JL; Sun D; Stuckey JA; Wang S
    Cancer Cell; 2019 Nov; 36(5):498-511.e17. PubMed ID: 31715132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual PLK1 and STAT3 inhibition promotes glioblastoma cells apoptosis through MYC.
    Wang H; Tao Z; Feng M; Li X; Deng Z; Zhao G; Yin H; Pan T; Chen G; Feng Z; Li Y; Zhou Y
    Biochem Biophys Res Commun; 2020 Dec; 533(3):368-375. PubMed ID: 32962858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of STAT3 and ErbB2 suppresses tumor growth, enhances radiosensitivity, and induces mitochondria-dependent apoptosis in glioma cells.
    Gao L; Li F; Dong B; Zhang J; Rao Y; Cong Y; Mao B; Chen X
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1223-31. PubMed ID: 20610043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutively activated STAT3 frequently coexpresses with epidermal growth factor receptor in high-grade gliomas and targeting STAT3 sensitizes them to Iressa and alkylators.
    Lo HW; Cao X; Zhu H; Ali-Osman F
    Clin Cancer Res; 2008 Oct; 14(19):6042-54. PubMed ID: 18829483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma.
    Miklossy G; Youn UJ; Yue P; Zhang M; Chen CH; Hilliard TS; Paladino D; Li Y; Choi J; Sarkaria JN; Kawakami JK; Wongwiwatthananukit S; Chen Y; Sun D; Chang LC; Turkson J
    J Med Chem; 2015 Oct; 58(19):7734-48. PubMed ID: 26331426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner.
    Kiprianova I; Remy J; Milosch N; Mohrenz IV; Seifert V; Aigner A; Kögel D
    Neoplasia; 2015 Jul; 17(7):564-73. PubMed ID: 26297434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel small molecular inhibitors disrupt the JAK/STAT3 and FAK signaling pathways and exhibit a potent antitumor activity in glioma cells.
    Swiatek-Machado K; Mieczkowski J; Ellert-Miklaszewska A; Swierk P; Fokt I; Szymanski S; Skora S; Szeja W; Grynkiewicz G; Lesyng B; Priebe W; Kaminska B
    Cancer Biol Ther; 2012 Jun; 13(8):657-70. PubMed ID: 22555804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma.
    Pan Y; Zhou F; Zhang R; Claret FX
    PLoS One; 2013; 8(1):e54565. PubMed ID: 23382914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.